farnesol has been researched along with organophosphonates in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parker, TS; Popják, G; Sutherland, K; Wong, SM | 1 |
| Gibbs, JB; Kohl, NE; Lingham, RB; Mosser, SD; Oliff, A; Pompliano, DL; Rands, E; Scolnick, EM; Singh, SB | 1 |
| Carel, K; Draznin, B; Heidenreich, KA; Kummer, JL; Leitner, W; Schubert, C | 1 |
| Brown, BE; Denda, M; Elias, PM; Feingold, KR | 1 |
| Carel, K; Draznin, B; Goalstone, M; Kline, T; Leitner, JW | 1 |
| Blazer-Yost, BL; Hughes, CL; Nolan, PL | 1 |
| Meigs, TE; Simoni, RD | 1 |
| Cermak, DM; Hohl, RJ; Lewis, KA; Wiemer, DF | 1 |
| Ghassemian, M; Kwak, CM; McCourt, P; Pei, ZM; Schroeder, JI | 1 |
| Beese, LS; Bond, R; Le, HV; Schwartz, J; Strickland, CL; Syto, R; Wang, L; Weber, PC; Windsor, WT; Wu, Z | 1 |
| Kabir, AN; Marber, MS; Mockridge, JW; Rakhit, RD; Saurin, A | 1 |
| Du, Y; Wiemer, DF | 1 |
| Wells, PG; Winn, LM | 1 |
| Cornish, K; Garneau, S; Mau, CJ; Scholte, AA; Van Fleet, JE; Vederas, JC | 1 |
| Alves, V; Andrade, C; Casalta-Lopes, J; Costa, CB; Dourado, M; Gonçalves, AC; Moreira, D; Nascimento-Costa, JM; Oliveira, A; Sarmento-Ribeiro, AB; Silva, T | 1 |
15 other study(ies) available for farnesol and organophosphonates
| Article | Year |
|---|---|
Inhibition of liver prenyltransferase by alkyl phosphonates and phosphonophosphates.
Topics: Animals; Binding Sites; Cholesterol; Dimethylallyltranstransferase; Farnesol; Kinetics; Liver; Mevalonic Acid; Organophosphonates; Polyisoprenyl Phosphates; Sesquiterpenes; Structure-Activity Relationship; Swine; Transferases | 1978 |
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cattle; Cell Line, Transformed; Farnesol; Gene Expression Regulation; Genes, ras; Kinetics; Maleates; Mice; Organophosphonates; Organophosphorus Compounds; Protein Processing, Post-Translational; Transferases; Tricarboxylic Acids | 1993 |
Insulin stimulates mitogen-activated protein kinase by a Ras-independent pathway in 3T3-L1 adipocytes.
Topics: Adipocytes; Alkyl and Aryl Transferases; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Guanosine Triphosphate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Lovastatin; Mice; Organophosphonates; Organophosphorus Compounds; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Proto-Oncogene Proteins p21(ras); Rats; Signal Transduction; Transferases | 1996 |
Epidermal injury stimulates prenylation in the epidermis of hairless mice.
Topics: Alkyl and Aryl Transferases; Animals; Basal Metabolism; Enzyme Inhibitors; Epidermis; Farnesol; Farnesyltranstransferase; Male; Mevalonic Acid; Mice; Mice, Hairless; Molecular Weight; Organophosphonates; Protein Prenylation; Radioligand Assay; Time Factors; Transferases; Tritium | 1997 |
Hyperinsulinemia potentiates activation of p21Ras by growth factors.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Drug Synergism; Enzyme Inhibitors; Epidermal Growth Factor; Farnesol; Farnesyltranstransferase; Growth Substances; Guanosine Triphosphate; Insulin; Insulin-Like Growth Factor I; Mice; Organophosphonates; Organophosphorus Compounds; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Transferases | 1997 |
Protein prenylation is required for aldosterone-stimulated Na+ transport.
Topics: Acetylcysteine; Aldosterone; Animals; Biological Transport; Cell Line; Cysteine; Dimethylallyltranstransferase; Diterpenes; Enzyme Inhibitors; Epithelium; Farnesol; Insulin; Kidney; Kinetics; Lovastatin; Organophosphonates; Protein Prenylation; Sodium | 1997 |
Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase.
Topics: Animals; beta-Galactosidase; CHO Cells; Cricetinae; Edetic Acid; Enzyme Inhibitors; Farnesol; Hydroxymethylglutaryl CoA Reductases; Magnesium; Mevalonic Acid; Organophosphonates; Phosphinic Acids; Pyrophosphatases; Recombinant Fusion Proteins | 1997 |
Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids.
Topics: Alkyl and Aryl Transferases; Cholesterol; Enzyme Inhibitors; Farnesol; Farnesyl-Diphosphate Farnesyltransferase; Humans; Leukemia; Molecular Conformation; Organophosphonates; Protein Prenylation; ras Proteins; Structure-Activity Relationship; Substrate Specificity; Tumor Cells, Cultured | 1998 |
Role of farnesyltransferase in ABA regulation of guard cell anion channels and plant water loss.
Topics: Abscisic Acid; Alkyl and Aryl Transferases; Anions; Arabidopsis; Arabidopsis Proteins; Enzyme Inhibitors; Farnesol; Gene Deletion; Gene Expression; Genes, Plant; Ion Channels; Mutation; Organophosphonates; Patch-Clamp Techniques; Phosphoprotein Phosphatases; Plant Leaves; Plants, Genetically Modified; Polyenes; Polyunsaturated Alkamides; Protein Prenylation; Signal Transduction; Water | 1998 |
Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue.
Topics: Alkyl and Aryl Transferases; Animals; Binding Sites; Crystallization; Crystallography, X-Ray; Farnesol; Humans; Macromolecular Substances; Models, Molecular; Oligopeptides; Organophosphonates; Polyisoprenyl Phosphates; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Sesquiterpenes; Substrate Specificity | 1998 |
Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury.
Topics: Adenoviridae; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Farnesol; GTP-Binding Proteins; Humans; Imidazoles; Ischemic Preconditioning, Myocardial; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Myocardium; Nitric Oxide; Organophosphonates; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Protein Isoforms; Protein Kinase C; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors | 2001 |
Alpha-phosphono lactone analogues of farnesyl pyrophosphate: an asymmetric synthesis via ring-closing metathesis.
Topics: Ether; Farnesol; Furans; Indicators and Reagents; Isomerism; Lactones; Molecular Conformation; Organophosphonates; Polyisoprenyl Phosphates; Sesquiterpenes; Structure-Activity Relationship | 2002 |
Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; DNA; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Embryonic and Fetal Development; Farnesol; Female; Gene Expression Regulation, Developmental; Genes, ras; Mice; Mice, Inbred A; Oncogene Protein p21(ras); Organ Culture Techniques; Organophosphonates; Phenytoin; Pregnancy; Signal Transduction; Species Specificity; Teratogens | 2002 |
Protein farnesyltransferase inhibitors interfere with farnesyl diphosphate binding by rubber transferase.
Topics: Alkyl and Aryl Transferases; Asteraceae; Binding Sites; Dimethylallyltranstransferase; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Glutarates; Hevea; Kinetics; Lithium Compounds; Maleates; Organophosphonates; Polyisoprenyl Phosphates; Salts; Sesquiterpenes; Solvents; Species Specificity | 2003 |
Farnesyltransferase inhibitors: molecular evidence of therapeutic efficacy in acute lymphoblastic leukemia through cyclin D1 inhibition.
Topics: Cell Line, Tumor; Cyclin D1; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Humans; Organophosphonates; Phosphorous Acids; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2012 |